ATE427499T1 - Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen - Google Patents

Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen

Info

Publication number
ATE427499T1
ATE427499T1 AT05751819T AT05751819T ATE427499T1 AT E427499 T1 ATE427499 T1 AT E427499T1 AT 05751819 T AT05751819 T AT 05751819T AT 05751819 T AT05751819 T AT 05751819T AT E427499 T1 ATE427499 T1 AT E427499T1
Authority
AT
Austria
Prior art keywords
compositions
methods
serum glycoproteins
quantifying serum
quantifying
Prior art date
Application number
AT05751819T
Other languages
English (en)
Inventor
Rudolph Aebersold
Hui Zhang
Original Assignee
Inst Systems Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Systems Biology filed Critical Inst Systems Biology
Application granted granted Critical
Publication of ATE427499T1 publication Critical patent/ATE427499T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
AT05751819T 2004-05-21 2005-05-20 Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen ATE427499T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57359304P 2004-05-21 2004-05-21

Publications (1)

Publication Number Publication Date
ATE427499T1 true ATE427499T1 (de) 2009-04-15

Family

ID=35429005

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05751819T ATE427499T1 (de) 2004-05-21 2005-05-20 Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen

Country Status (6)

Country Link
US (2) US20060141528A1 (de)
EP (4) EP2302393A1 (de)
AT (1) ATE427499T1 (de)
DE (1) DE602005013670D1 (de)
DK (1) DK1766412T3 (de)
WO (1) WO2005114221A2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344456T1 (de) * 2000-05-05 2006-11-15 Purdue Research Foundation Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
US7449170B2 (en) * 2001-09-27 2008-11-11 Purdue Research Foundation Materials and methods for controlling isotope effects during fractionation of analytes
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US7384754B2 (en) * 2003-10-31 2008-06-10 Agilent Technologies, Inc. Enrichment and tagging of glycosylated proteins
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1938104A2 (de) * 2005-10-17 2008-07-02 Institute for Systems Biology Von gewebe und serum abgeleitete glycoproteine, und methoden zu deren verwendung
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
EP2057465A4 (de) * 2006-08-09 2010-04-21 Homestead Clinical Corp Organspezifische proteine und anwendungsverfahren dafür
US7879799B2 (en) * 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
EP2155228B1 (de) 2007-01-10 2014-04-02 Purdue Research Foundation Polypeptid-inhibitoren der hsp27-kinase und ihre verwendungen
US20100184049A1 (en) * 2007-04-27 2010-07-22 Steve Goodison Glycoprotein Profiling of Bladder Cancer
US8603734B2 (en) * 2007-06-04 2013-12-10 The Johns Hopkins University Biomarkers for prostate cancer
WO2008154619A1 (en) * 2007-06-12 2008-12-18 Smithkline Beecham Corporation Methods for detecting protein in plasma
US20100168382A1 (en) * 2007-06-12 2010-07-01 Vladimir Berezin Neuroplastin derived peptides
US8628912B2 (en) * 2007-07-03 2014-01-14 Northeastern University Biomarkers for diabetes, obesity, and/or hypertension
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
JP5703466B2 (ja) 2007-08-07 2015-04-22 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ キナーゼ阻害薬およびその使用
WO2009095925A2 (en) * 2008-01-31 2009-08-06 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
CN105920582B (zh) 2008-12-10 2020-04-14 普渡研究基金会 基于细胞渗透性肽的激酶抑制剂
US8395113B2 (en) 2009-05-08 2013-03-12 Thermo Finnigan Llc Methods and systems for matching product ions to precursor in tandem mass spectrometry
US9796761B2 (en) * 2009-07-14 2017-10-24 National Institute Of Advanced Industrial Science And Technology Glycan markers as measure of disease state of hepatic diseases
WO2011017132A2 (en) 2009-07-27 2011-02-10 Purdue Research, Foundation Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
EP2569627B1 (de) * 2010-05-14 2019-09-18 DH Technologies Development Pte. Ltd. Systeme und verfahren zur berechnung von proteinkonfidenzwerten
EA034494B1 (ru) * 2010-10-27 2020-02-13 Баксалта Инкорпорейтид Пептид фактора viii для индуцирования иммунной толерантности и иммунодиагностики
US9403889B2 (en) 2010-11-29 2016-08-02 Integrated Diagnostics, Inc. Diagnostic lung cancer panel and methods for its use
US8772043B2 (en) 2010-12-23 2014-07-08 Pioneer Hi Bred International Inc Universal peptide tags for transgene polypeptide analysis by mass spectrometry
CA2835806A1 (en) * 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
US8455624B2 (en) 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
US9506167B2 (en) 2011-07-29 2016-11-29 Ginkgo Bioworks, Inc. Methods and systems for cell state quantification
CN104081202A (zh) 2011-09-12 2014-10-01 克里蒂科斯有限责任公司 检测靶分子的非侵入性方法
CN103134874B (zh) * 2011-12-01 2015-05-20 成都康弘生物科技有限公司 一种测定蛋白中糖基的方法
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9201044B2 (en) 2011-12-21 2015-12-01 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
EP2802338B1 (de) * 2012-01-09 2018-03-07 Serpin Pharma, LLC Peptide und verwendungsverfahren dafür
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
EP2918600B1 (de) * 2012-11-06 2019-04-24 University of Miyazaki Neuartiges peptid und verwendung davon
WO2014100717A2 (en) 2012-12-21 2014-06-26 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
EP2972375A2 (de) 2013-03-13 2016-01-20 Creatics LLC Verfahren und zusammensetzungen zur erkennung von bauchspeicheldrüsenkrebs
GB201310150D0 (en) * 2013-06-07 2013-07-24 Electrophoretics Ltd Methods and compositions relating to alzheimer's disease
US9297805B2 (en) 2013-07-26 2016-03-29 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9594085B2 (en) 2014-02-03 2017-03-14 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
US10000533B2 (en) 2014-06-20 2018-06-19 Immatics Biotechnologies Gmbh Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
GB201411037D0 (en) * 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
WO2016038608A1 (en) * 2014-09-08 2016-03-17 Carmel Haifa University Economic Corporation Ltd. Peptides derived from angiotensin receptor and use thereof
US10035823B2 (en) * 2014-09-29 2018-07-31 The Regents Of The University Of California Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
IL254129B2 (en) 2015-03-27 2023-10-01 Immatics Biotechnologies Gmbh New peptides and a combination of peptides for use in immunotherapy against various tumors
CN113429455A (zh) 2015-08-28 2021-09-24 赛品制药有限责任公司 用于疾病治疗的方法
GB201520559D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
US10802027B2 (en) 2016-05-05 2020-10-13 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9960027B2 (en) 2016-05-25 2018-05-01 Thermo Finnigan Llc Analyzing a complex sample by MS/MS using isotopically-labeled standards
KR102633621B1 (ko) * 2017-09-01 2024-02-05 벤 바이오사이언시스 코포레이션 진단 및 치료 모니터링용 바이오마커로서의 당펩티드의 식별 및 용도
ES2710321A1 (es) * 2017-10-20 2019-04-24 Consejo Superior Investigacion Adn polimerasas independientes de cebador y su uso para la sintesis de adn
WO2020223646A1 (en) 2019-05-02 2020-11-05 Creatics Llc Methods for cancer detection by evaluation of alpha-1-antitrypsin (aat) and chymotrypsin-like elastase in gastrointestinal lavage fluid samples
CN110563844A (zh) * 2019-09-04 2019-12-13 华中农业大学 一种抗犬白介素31受体的多克隆抗体及其应用
WO2021050510A1 (en) * 2019-09-09 2021-03-18 The Wistar Institute Of Anatomy And Biology Engineered peptide and peptide mimetic compositions and methods
CA3181406A1 (en) * 2020-04-28 2021-11-04 Janssen Pharmaceuticals, Inc. Method for identification and quantification of polysaccharides in complex glycoconjugate compositions
US12105093B2 (en) 2020-07-28 2024-10-01 University Of Washington Quantitation of GLA proteins by mass spectrometric analysis
US20240219400A1 (en) * 2021-04-29 2024-07-04 Seer, Inc. Peptide decorated nanoparticles for enrichment of specific protein subsets
CN113480629B (zh) * 2021-06-16 2022-08-19 复旦大学 区分肝癌和正常人的末端唾液酸化异构糖肽标志物及其筛查方法
US11542340B1 (en) 2021-10-29 2023-01-03 Biodesix, Inc. Antibodies targeting pulmonary nodule specific biomarkers and uses thereof
NL2030990B1 (en) * 2022-02-17 2023-09-01 Academisch Ziekenhuis Leiden T cell receptors directed against jchain and uses thereof
US20240228671A1 (en) * 2022-10-21 2024-07-11 Quantum-Si Incorporated Polypeptidyl linkers
CN117969642B (zh) * 2024-04-02 2024-07-23 浙江大学 一种植物n-糖链的精准相对定量分析方法及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226032B (en) * 1988-12-16 1993-08-18 Urs Heimgartner Detection of glycoproteins
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
US5986076A (en) 1994-05-11 1999-11-16 Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
JPH10507160A (ja) 1994-06-23 1998-07-14 アフィマックス テクノロジーズ エヌ．ブイ． 光活性化合物およびその使用方法
EP1378525A3 (de) * 1996-06-07 2004-01-14 Neorx Corporation Humanisierte Antikörper die and das gleiche Antigen wie Antikörper NR-LU-13 binden und deren Verwendung in "Pretargeting" Verfahren
EP0959893A4 (de) * 1996-12-10 2004-11-10 Sloan Kettering Institutefor C Stimulierung einer immunantwort auf ein differentiationsantigen, das durch ein verändertes antigen stimuliert wird
US6046013A (en) * 1997-08-01 2000-04-04 Gti Process for identifying specific antibodies associated with HLA
WO2000011208A1 (en) 1998-08-25 2000-03-02 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
US6407210B1 (en) * 1998-11-09 2002-06-18 University Of Utah Research Foundation Nematode neuromuscular junction GABA receptors and methods related thereto
JP2003518364A (ja) * 1999-05-28 2003-06-10 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 乳癌、胃癌および前立腺癌関連抗原ならびにそれらの使用
CA2433281C (en) 2000-12-26 2011-02-22 The Institute For Systems Biology Rapid and quantitative proteome analysis and related methods
EP1435957B1 (de) * 2001-04-30 2009-06-17 Vertex Pharmaceuticals Incorporated Inhibitoren von gsk-3 und kristallstrukturen von gsk-3beta-protein und -proteinkomplexen
US7449170B2 (en) * 2001-09-27 2008-11-11 Purdue Research Foundation Materials and methods for controlling isotope effects during fractionation of analytes
EP1514107B1 (de) * 2002-06-03 2013-05-15 The Institute for Systems Biology Verfahren zur quantitativen proteomanalyse von glycoproteinen
WO2005007677A2 (en) * 2003-07-10 2005-01-27 The Institute For Systems Biology Affinity capture of peptides by microarray and related methods
US7593336B2 (en) * 2003-10-31 2009-09-22 Brocade Communications Systems, Inc. Logical ports in trunking
US7348416B2 (en) * 2003-11-21 2008-03-25 Applera Corporation Selective capture and enrichment of proteins expressed on the cell surface

Also Published As

Publication number Publication date
US20060141528A1 (en) 2006-06-29
EP2302393A8 (de) 2011-08-03
WO2005114221A3 (en) 2006-12-21
WO2005114221A8 (en) 2006-05-04
DE602005013670D1 (de) 2009-05-14
WO2005114221A2 (en) 2005-12-01
EP2093569A2 (de) 2009-08-26
EP2302393A1 (de) 2011-03-30
US20100279382A1 (en) 2010-11-04
EP1766412B1 (de) 2009-04-01
EP1766412A2 (de) 2007-03-28
EP2093569A3 (de) 2009-11-11
EP2302394A1 (de) 2011-03-30
DK1766412T3 (da) 2009-05-25

Similar Documents

Publication Publication Date Title
ATE427499T1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
ATE324106T1 (de) Zusammensetzungen und verfahren zur regulierung des serumcholesterins
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE60214060D1 (de) Vorrichtung zur Bereitstellung von Wegbeschreibung
DE60026452D1 (de) Verfahren zur Identifizierung von Peptidensequenzen und Proteinensequenzen mittels Massenspektromterie
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DE60237905D1 (de) Set zur Entnahme von Knochenmark
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
ATE520466T1 (de) Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen
WO2005012574A3 (en) Biological bar-code
EP1468287A4 (de) Automatische systeme und verfahren zur analyse der posttranslationalen proteinmodifikation
DE50213709D1 (de) Verfahren zur bereitstellung von zielführungshinweisen
DE60229204D1 (de) Prozessor und Verfahren zur Urladung desselben
ATA1112001A (de) Verfahren zur tragekontrolle von regulierungen
DE50214217D1 (de) Verfahren zur ermittlung des ladezustands und/oder
DE60235170D1 (de) Detektionsverfahren und verfahren zur quantitativen analyse von wasserstoffradikalen
DE60028114D1 (de) Verfahren zur Analyse von ausgeatmetem Gas
DE602004032465D1 (de) Referenzstandard zur charakterisierung von rosuvastatin
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE60315575D1 (de) Verfahren und Vorrichtung zur Untersuchung von Oberflächen
DE69916247D1 (de) Vorrichtung zur fixierung von knochenbrüchen
DE50204097D1 (de) Verfahren zur ermittlung von auswirkungen von konstruktionsentscheidungen
DE60212032D1 (de) Systemen und Verfahren zur Koordinierung von Quälitätssicherungsereignissen
DE69941317D1 (de) Verfahren zur Untersuchung von Gasen
EP1468265A4 (de) Systeme und verfahren zur proteinphosphorylierungsanalyse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties